Literature DB >> 19715174

[A marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepiness].

Tomoaki Iwata1, Naoki Suzuki, Hideki Mizuno, Ichiro Nakashima, Takashi Kanbayashi, Yasuto Itoyama.   

Abstract

Excessive daytime somnolence is one of the common complaints in patients with myotonic dystrophy. Here we report a 60-year-old female case of myotonic dystrophy type 1 with narcolepsy due to medical condition. The size of the CTG repeat in the 3' untranslated region of the DMPK gene was 1,800-2,400 repeats. Brain MRI was normal. Polysomnography revealed sleep apnea and chronic alveolar hypoventilation. Multiple sleep latency tests revealed normal sleep latencies and sleep onset REM was not observed. Orexin/hypocretin in the cerebrospinal fluid was markedly decreased to an undetectable level. Such sleep-related disorders may worsen the quality of life and possibly cause sudden death in patients with myotonic dystrophy. Narcolepsy associated with myotonic dystrophy should be evaluated appropriately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715174     DOI: 10.5692/clinicalneurol.49.437

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

Review 1.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

2.  Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness.

Authors:  Yuki Omori; Takashi Kanbayashi; Aya Imanishi; Ko Tsutsui; Yohei Sagawa; Yuka S Kikuchi; Masahiro Takeshima; Kazuhisa Yoshizawa; Sachiko Uemura; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-08       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.